Jeffrey G. Lamothe - 28 Jan 2024 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role: EVP, COO
Signature: /s/ SoYoung Kwon, Attorney-in-Fact
Issuer symbol: APVO
Transactions as of: 28 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 30 Jan 2024, 18:04:47 UTC
Previous filing: 10 Aug 2023
Next filing: 05 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APVO	Common Stock	Options Exercise		+1,833	+6.9%		28,337	28 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	-1,833	-100%	$0.000000^*	0	28 Jan 2024	Common Stock	1,833		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2	On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 28, 2022.